OakChart

Neumora Therapeutics Inc

NMRAHealthcare·Biotechnology·USA·Micro·NASD·Nov 11 • 3:59 PM ET

0.4730+0.0064 (1.37%)
2026-11-12 04:31 CET
Market cap
88.87 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-212.74 USD m
Free cash flow, TTM
-180.97 USD m
EPS diluted, TTM
-1.23
P/E
-
Compare

Price

NMRA against its 20, 50 and 200-day averages
2050200miss
0.501.001.502.002.5014.3M28.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NMRAclose 0.4720-day 0.4550-day 0.64200-day 1.720.4752w low

87.0% under the 52-week high of 3.65 on 18 Feb 2026. 52-week low 0.32 on 14 Oct 2026. Last 15 sessions, 84.7% high to low

Volume 0.30× normal · the line is the 50-bar volume average

Profile

NMRA
52-week range, 5% of the way up
0.323.65

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. The firm offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. It focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.

IndexRUT
Employees96
IPOSep 15, 2023
Beta2.96
ATR, 14d0.08
Rel volume0.30
Short float8.84%
Insider own57.80%
Inst own27.34%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap88.87M
Enterprise Value25.29M
Income-212.74M
Sales0.00M
Book/sh0.24
Cash/sh0.62
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees96
IPOSep 15, 2023

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B1.99
P/C0.76
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio4.50
Current Ratio4.50
Debt/Eq1.20
LT Debt/Eq1.19
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.23
EPS next Y-0.62
EPS next Q-0.20
EPS this Y37.64%
EPS next Y31.11%
EPS next 5Y22.62%
EPS past 3/5Y-18.95% -17.29%
Sales past 3/5Y- -
EPS Y/Y TTM21.31%
Sales Y/Y TTM-
EPS Q/Q28.64%
Sales Q/Q-
EarningsAug 14 BMO
EPS/Sales Surpr.4.21% -

Ownership

Insider Own57.80%
Insider Trans-0.42%
Inst Own27.34%
Inst Trans3.27%
ROA-121.89%
ROE-187.11%
ROIC-218.26%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA205.17%
SMA50-25.93%
SMA200-72.46%
Trades-

Technical

Shs Outstand186.85M
Shs Float79.28M
Short Float8.84%
Short Ratio4.25
Short Interest7.01M
52W High3.65 -87.04%
52W Low0.32 49.97%
Volatility16.23% 18.03%
ATR (14)0.08
RSI (14)45.04
Beta2.96
Rel Volume0.30
Avg Volume1.65M
Volume491,107

Performance

Perf Week-16.43%
Perf Month27.77%
Perf Quarter-72.66%
Perf Half Y-73.43%
Perf YTD-73.58%
Perf Year-82.80%
Perf 3Y-95.92%
Perf 5Y-
Perf 10Y-
Recom1.50
Target Price6.50
Prev Close0.47
Price0.47
Change %1.37%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jun 16, 2026ReiteratedNNeedhamBuy$8 → $5+957.1%
Jun 16, 2026ReiteratedHH.C. WainwrightBuy$18 → $7+1,379.9%
Feb 17, 2026UpgradeWWilliam BlairMkt Perform → Outperform
Jan 12, 2026InitiatedLLeerink PartnersOutperform$8+1,591.3%
Dec 01, 2025UpgradeRRBC Capital MktsSector Perform → Outperform$7+1,379.9%
Oct 27, 2025UpgradeGGuggenheimNeutral → Buy$14+2,859.8%
Sep 16, 2025DowngradeJJP MorganNeutral → Underweight
Apr 02, 2025DowngradeBBofA SecuritiesBuy → Underperform$1+111.4%
Mar 10, 2025DowngradeWWilliam BlairOutperform → Mkt Perform
Mar 07, 2025DowngradeSStifelBuy → Hold$6 → $2+322.8%

Peers

Mkt cap
TickerCompanyMkt cap
ANROAlto Neuroscience Inc1.22B
AXSMAxsome Therapeutics Inc7.85B
SPTXSeaport Therapeutics Inc1.14B
DFTXDefinium Therapeutics Inc4.72B
HELPHelus Pharma Inc686.03M
NERVMinerva Neurosciences Inc127.58M
MPLTMapLight Therapeutics Inc415.70M
GHRSGH Research PLC1.32B
DRUGBright Minds Biosciences Inc231.32M
VTGNVistagen Therapeutics Inc8.34M

Insider trading

latest 14 of 33
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Aurora Daljit SinghSee RemarksAug 20 '26Option Exercise0.7267,74148,774116,491Aug 21 07:10 PM
Aurora Daljit SinghSee RemarksAug 20 '26Option Exercise0.7266,71148,03266,711Aug 21 07:10 PM
Aurora Daljit SinghSee RemarksAug 21 '26Option Exercise0.7221,05515,16021,055Aug 21 07:10 PM
Aurora Daljit SinghSee RemarksAug 21 '26Option Exercise0.7220,55314,79869,303Aug 21 07:10 PM
Aurora Daljit SinghSee RemarksAug 20 '26Sale1.5167,741102,58748,750Aug 21 07:10 PM
Aurora Daljit SinghSee RemarksAug 20 '26Sale1.5166,711101,0000Aug 21 07:10 PM
Aurora Daljit SinghSee RemarksAug 21 '26Sale1.6021,05533,6000Aug 21 07:10 PM
Aurora Daljit SinghSee RemarksAug 21 '26Sale1.5920,55332,78048,750Aug 21 07:10 PM
Aurora Daljit SinghOfficerAug 21 '26Proposed Sale1.6041,60866,380Aug 21 04:34 PM
Aurora Daljit SinghOfficerAug 20 '26Proposed Sale1.51134,452203,584Aug 20 04:22 PM
Aurora Daljit SinghSee RemarksAug 17 '26Option Exercise0.7257,67041,522140,440Aug 19 07:17 PM
Aurora Daljit SinghSee RemarksAug 17 '26Option Exercise0.7255,01639,61255,016Aug 19 07:17 PM
Aurora Daljit SinghSee RemarksAug 18 '26Option Exercise0.7234,98725,19134,987Aug 19 07:17 PM
Aurora Daljit SinghSee RemarksAug 18 '26Option Exercise0.7234,16224,59782,912Aug 19 07:17 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IBBiShares Biotechnology ETFAUM: 11.36B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
IWCiShares Micro-Cap ETFAUM: 1.22B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
VHTVanguard Health Care ETFAUM: 21.51B

News

latest 14 of 198

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-08-14-0.230-0.240-0.2310.000.009
2026Q12026-05-07-0.300-0.316-0.2970.000.008
2025Q42026-03-30-0.350-0.325-0.3530.000.009
2025Q32025-11-06-0.350-0.333-0.3510.000.008
2025Q22025-08-06-0.330-0.363-0.3260.000.007
2025Q12025-05-12-0.420-0.374-0.4210.000.007
2024Q42025-03-03-0.370-0.424-0.3650.000.008
2024Q32024-11-12-0.450-0.391-0.4550.000.008
2024Q22024-08-06-0.370-0.372-0.3690.000.007
2024Q12024-05-07-0.340-0.342-0.3370.000.005
2023Q42024-03-07-0.710-0.551-0.6850.000.006
2023Q32023-11-01-1.140-0.347-0.3470.000.005
2026Q3---0.197--0.008
2026Q4---0.174--0.008
2027Q1---0.154--0.004
2027Q2---0.157--0.004

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2023FY-3.630-1.749-1.4850.000.00
2024FY-1.530-1.575-1.5300.000.00
2025FY-1.450-1.424-1.4500.000.00
2026FY--0.904--0.00
2027FY--0.623--0.00
2028FY--0.672--3.00
2029FY--0.613--74.96
2030FY--0.221--224.25

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-08-147000.000.000.00
2026Q3S2026-05-077000.000.000.00
2026Q3S2026-04-017000.000.000.00
2026Q3S2026-03-306000.000.000.00
2026Q3S2026-01-294000.000.000.00
2026Q3S2025-11-113000.000.000.00
2026Q3S2025-11-103000.000.000.00
2026Q3S2025-11-093000.000.000.00
2026Q3S2025-11-083000.000.000.00
2026Q3S2025-11-073000.000.000.00
2026Q3S2025-11-063000.000.000.00
2026Q3S2025-11-053000.000.000.00
2026Q3S2025-11-043000.000.000.00
2026Q3S2025-11-033000.000.000.00

Estimate history

EPS, annual0-0.653-1.562-0.862-1.485-1.53-1.45-1.2333
Period2019202020212022202320242025TTM
EPS, quarterly-0.369-0.455-0.365-0.421-0.326-0.351-0.353-0.297-0.233
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual00000000
Period2019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual151.949151.949151.949151.949158.832161.71174.26186.851
Period2019202020212022202320242025MRQ
Shares, quarterly159.95160.48161.71161.748161.947161.947174.26182.157186.851
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.050.210.630.672.701.550.100.00
Gross Profit-0.05-0.21-0.63-0.67-2.70-1.55-0.100.00
Selling, General and Administrative Excl. Other206.19235.95262.83187.53120.1778.7725.900.02
Research and Development153.07176.06200.93142.7291.7555.7817.610.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-206.23-236.16-263.46-188.19-122.87-80.32-26.01-0.02
Interest Expense6.463.220.000.000.000.00-0.00
Unusual Expense5.005.000.0063.9012.44156.9572.790.00
Net Income Before Taxes-212.71-236.80-243.61-235.66-130.90-237.31-99.27-0.02
Income Taxes0.030.130.180.270.000.000.000.00
Consolidated Net Income-212.74-236.93-243.79-235.93-130.90-237.31-99.27-0.02
Net Income From Continuing Operations-212.74-236.93-243.79-235.93-130.90-237.31-99.27-0.02
Net Income-212.74-236.93-243.79-235.93-130.90-237.31-99.27-0.02
EPS (Recurring)-1.13-1.43-1.53-1.20-0.80-0.84-0.32-0.00
EPS (Basic, Before Extraordinaries)-1.23-1.45-1.53-1.49-0.86-1.56-0.65-0.00
EPS (Diluted)-1.23-1.45-1.53-1.49-0.86-1.56-0.65-0.00
EBITDA-206.19-235.95-262.83-187.53-120.17-78.77-25.90-0.02
Non-Operating Income (Expense)4.987.5819.8616.444.41-0.04-0.480.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense23.6123.6031.5913.628.304.271.680.00
Shares Outstanding186.85174.26161.71158.83151.95151.95151.95151.95
Market Capitalization88.8788.871,712.552,603.502,603.50---

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.010.010.010.020.020.160.160.16
Gross Profit-0.01-0.01-0.01-0.02-0.02-0.16-0.16-0.16
Selling, General and Administrative Excl. Other42.1852.8658.4752.6854.0270.7862.7776.49
Research and Development29.2838.6044.6740.5238.7252.1545.9160.63
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-42.19-52.86-58.48-52.70-54.04-70.94-62.92-76.65
Interest Expense1.821.852.040.75-0.000.000.00
Unusual Expense0.000.000.005.000.000.000.000.00
Net Income Before Taxes-43.08-53.43-59.45-56.76-52.71-67.89-58.82-72.49
Income Taxes0.000.030.000.000.030.100.000.05
Consolidated Net Income-43.08-53.46-59.45-56.76-52.73-67.99-58.82-72.55
Net Income From Continuing Operations-43.08-53.46-59.45-56.76-52.73-67.99-58.82-72.55
Net Income-43.08-53.46-59.45-56.76-52.73-67.99-58.82-72.55
EPS (Recurring)-0.23-0.30-0.35-0.33-0.33-0.42-0.37-0.45
EPS (Basic, Before Extraordinaries)-0.23-0.30-0.35-0.35-0.33-0.42-0.37-0.45
EPS (Diluted)-0.23-0.30-0.35-0.35-0.33-0.42-0.37-0.45
EBITDA-42.18-52.86-58.47-52.68-54.02-70.78-62.77-76.49
Non-Operating Income (Expense)0.931.291.071.691.333.054.104.15
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense7.185.855.854.725.667.377.827.86
Shares Outstanding186.85182.16174.26161.95161.95161.75161.71160.48
Market Capitalization88.87325.82299.09294.74118.61161.981,712.552,113.97

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments182.53308.79453.98371.93409.37192.100.00
Short Term Receivables0.000.000.940.920.200.150.00
Inventories0.000.000.000.000.000.000.00
Other Current Assets8.015.2623.3615.106.031.590.00
Total Current Assets190.54314.06478.28387.95415.60193.840.00
Net Property, Plant & Equipment0.462.926.8610.644.043.920.00
Total Investments and Advances0.000.0011.0624.720.000.000.00
Intangible Assets-0.000.00---0.00
Deferred Tax Assets0.10------
Other Assets0.050.000.002.919.650.180.00
Total Assets191.15316.97496.19426.23429.30197.950.00
Short Term Debt Incl. Current Port. of LT Debt0.281.853.383.371.060.760.00
Accounts Payable3.383.310.347.151.642.400.00
Other Current Liabilities28.7924.7321.4013.1820.586.210.02
Total Current Liabilities32.4529.8925.1123.7023.289.370.02
Long Term Debt54.730.001.855.071.001.280.00
Provision for Risks Charges0.000.000.000.000.000.000.00
Deferred Tax Liabilities0.10------
Other Liabilities0.000.020.150.630.390.000.00
Total Liabilities87.2829.9127.1229.4024.6610.650.02
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.00843.69729.86281.680.00
Common Equity103.87287.06469.08-446.85-325.22-94.38-0.02
Total Shareholders Equity103.87287.06469.08396.84404.64187.29-0.02
Accumulated Minority Interest0.000.000.000.000.000.000.00
Total Equity103.87287.06469.08396.84404.64187.29-0.02
Total Liabilities & Stockholders Equity191.15316.97496.19426.23429.30197.950.00
Book Value Per Share0.601.782.95-2.94-2.14-0.62-0.00
Tangible Book Value Per Share0.601.782.95-2.94-2.14-0.62-0.00
Full-Time Employees961101241088853-
Price to Book Ratio1.995.305.085.08---
Return on Assets-93.26-59.96-51.15-30.60-75.67-100.30-
Return on Equity-121.21-64.48-54.49-32.67-80.18-106.02-
Return on Invested Capital-149.39-84.92-50.10-32.57-58.50-52.64-
Quick Ratio5.8710.5119.0516.3717.8520.690.00
Current Ratio5.8710.5119.0516.3717.8520.690.00

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-212.75-236.93-243.79-235.93-130.90-237.31-99.27-0.02
Depreciation0.050.210.630.672.701.550.100.00
Other Funds (Non Cash)28.9030.7237.5880.8820.26161.3075.530.00
Funds from Operations-183.80-206.00-205.57-154.38-107.95-74.46-23.64-0.02
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital2.83-0.4422.64-8.90-6.95-0.96-3.120.02
Cash from Operating Activities-180.97-206.44-182.94-163.28-114.90-75.42-26.760.00
Capital Expenditures0.000.000.00-4.71-13.51-0.82-1.300.00
Net Assets From Acquisitions0.000.00-0.780.000.000.000.000.00
Sale of Fixed Assets and Businesses0.200.220.000.000.000.002.810.00
Purchase or Sale of Investments93.83168.30-69.7869.09-154.500.00-12.750.00
Purchase of Investments0.00-82.87-312.22-109.07-226.370.00-12.750.00
Sale Or Maturity of Investments93.83251.17242.44178.1771.870.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities94.03168.52-70.5664.39-168.01-0.82-11.240.00
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock40.4819.9321.60231.94115.74293.51174.190.00
Repurchase of Common Pref Stock0.000.000.00-0.490.000.00-0.000.00
Sale of Common Pref Stock40.4819.9321.60232.43115.74293.51174.200.00
Proceedsfrom Stock Options39.9719.6514.12229.57111.47291.00174.200.00
Issuance or Reduction of Debt, Net38.7657.160.000.000.000.0055.910.00
Change in Long Term Debt38.7657.160.000.000.000.0055.910.00
Issuance of Long Term Debt38.7657.160.000.000.000.0055.910.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities79.2477.0921.60231.94115.74293.51230.100.00
Net Change in Cash-7.6939.17-231.89133.04-167.17217.27192.100.00
Free Cash Flow-180.97-206.44-182.94-163.40-115.41-76.24-28.060.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments116.83147.07182.53171.53217.59250.57
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets8.046.368.015.565.324.30
Total Current Assets124.87153.43190.54177.08222.91254.87
Net Property, Plant & Equipment0.320.390.460.550.621.88
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets-----0.00
Deferred Tax Assets--0.10---
Other Assets0.050.050.050.200.300.00
Total Assets125.25153.88191.15177.83223.82256.75
Short Term Debt Incl. Current Port. of LT Debt0.300.290.280.260.170.94
Accounts Payable4.155.063.380.550.641.05
Other Current Liabilities23.3324.7728.7925.0420.3426.39
Total Current Liabilities27.7830.1132.4525.8421.1628.38
Long Term Debt52.9553.0854.7319.8319.790.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities--0.10---
Other Liabilities0.000.000.000.000.000.00
Total Liabilities80.7383.2087.2845.6740.9528.38
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity44.5270.68103.87132.16182.88228.36
Total Shareholders Equity44.5270.68103.87132.16182.88228.36
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity44.5270.68103.87132.16182.88228.36
Total Liabilities & Stockholders Equity125.25153.88191.15177.83223.82256.75
Book Value Per Share0.240.390.600.821.131.41
Tangible Book Value Per Share0.240.390.600.821.131.41
Full-Time Employees--969596103
Price to Book Ratio1.993.272.191.610.520.56
Return on Assets-121.89-108.32-93.26-89.11-80.25-73.01
Return on Equity-187.11-148.74-121.21-104.35-89.37-79.05
Return on Invested Capital-44.20-43.19-37.48-37.34-26.02-29.77
Quick Ratio4.505.095.876.8510.548.98
Current Ratio4.505.095.876.8510.548.98

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-43.08-53.46-59.45-56.76-52.73-67.99
Depreciation0.010.010.010.020.020.16
Other Funds (Non Cash)7.197.818.285.627.918.91
Funds from Operations-35.88-45.64-51.16-51.12-44.80-58.92
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-4.09-0.773.214.48-7.60-0.53
Cash from Operating Activities-39.97-46.40-47.95-46.63-52.40-59.45
Capital Expenditures0.000.000.02-0.020.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.070.050.090.080.00
Purchase or Sale of Investments0.000.0042.5851.2530.3144.16
Purchase of Investments0.000.000.000.00-38.48-44.38
Sale Or Maturity of Investments0.000.0042.5851.2568.8088.55
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.000.0742.6551.3230.4044.16
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock9.7310.8819.870.000.060.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock9.7310.8819.870.000.060.00
Proceedsfrom Stock Options9.5010.8819.590.000.060.00
Issuance or Reduction of Debt, Net0.000.0038.90-0.1418.400.00
Change in Long Term Debt0.000.0038.90-0.1418.400.00
Issuance of Long Term Debt0.000.0038.90-0.1418.400.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities9.7310.8858.77-0.1418.460.00
Net Change in Cash-30.24-35.4653.464.55-3.55-15.29
Free Cash Flow-39.97-46.40-47.94-46.65-52.40-59.45

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-308.84%7.0M79.3M1.45M
2026-10-157.11%5.6M79.3M1.32M
2026-09-308.44%6.7M79.3M1.08M
2026-09-158.80%7.0M79.3M1.62M
2026-08-3110.37%8.0M77.4M1.87M
2026-08-1410.32%8.0M77.4M1.94M
2026-07-319.71%7.6M78.5M2.12M
2026-07-159.92%7.8M78.5M2.26M
2026-06-308.51%6.7M78.5M2.31M
2026-06-156.26%4.9M78.5M1.48M
2026-05-297.25%5.6M77.0M1.26M
2026-05-156.36%4.9M77.0M1.24M
2026-04-307.39%4.6M62.3M1.35M
2026-04-157.37%4.5M60.7M1.27M
2026-03-317.11%4.3M60.8M1.70M
2026-03-138.88%5.0M55.8M1.66M
2026-02-279.34%5.2M55.8M1.64M
2026-02-1310.83%6.0M55.8M1.65M
2026-01-309.73%5.6M57.9M1.57M
2026-01-1510.33%6.0M57.9M2.21M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.500.000.150.0811.98740.000.000.833-0.0130.000
call1.000.004.900.035.2054810.000.299-0.0070.000
call1.500.000.750.006.5520.000.000.265-0.0090.000
call2.000.002.000.007.4140.000.000.249-0.0100.000
call2.500.004.900.008.0430.000.000.239-0.0100.000
call5.000.000.750.009.8270.000.000.217-0.0120.000
call7.500.000.050.0510.2352.000.000.208-0.0120.000
put0.500.000.400.0016.2730.000.00-0.167-0.0130.000
put1.000.301.300.500.0001.000.00-0.701-0.0070.000
put1.500.801.551.100.0001.001.00-0.735-0.0090.000
put2.001.104.901.600.0002.001.00-0.751-0.0100.000
put2.501.604.902.100.0001.001.00-0.761-0.0100.000
put5.002.106.504.500.0002.000.00-0.783-0.0110.000
put7.506.607.607.100.0001.001.00-0.792-0.0120.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-308-KCurrent report2026-10-26SEC
2026-08-21144Filing for proposed sale of securities under Rule 144.SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-20144Filing for proposed sale of securities under Rule 144.SEC
2026-08-19144Filing for proposed sale of securities under Rule 144.SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-18144Filing for proposed sale of securities under Rule 144.SEC
2026-08-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-148-KCurrent report2026-08-14SEC
2026-07-278-KCurrent report2026-07-27SEC
2026-06-158-KCurrent report2026-06-10SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-298-KCurrent report2026-05-27SEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-04-17DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-17DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-05-27SEC
2026-04-01SCHEDULE 13D/ASEC
2026-03-30S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-03-3010-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0800701.64K10
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020082.59K4
2026-010000
2025-120000
2025-1100307.03K1

Institutional holders

Manager% owned
Siren, L.L.C.4.59%
BlackRock, Inc.4.21%
SOFTBANK GROUP CORP.3.29%
VANGUARD CAPITAL MANAGEMENT LLC2.52%
MIC Capital Management UK LLP2.41%
WELLCOME TRUST LTD1.79%
GEODE CAPITAL MANAGEMENT, LLC1.49%
FMR LLC1.39%
ICONIQ Capital, LLC1.38%
TWO SIGMA INVESTMENTS, LP1.21%

Funds

Fund% owned
Global X Copper Miners ETF22.71%
Global X Uranium ETF11.34%
Global X Artificial Intelligence & Technology ETF7.03%
Global X Cybersecurity ETF3.31%
Global X SuperDividend ETF2.74%
Global X Autonomous & Electric Vehicles ETF2.72%
Global X Silver Miners ETF2.48%
Global X Robotics & Artificial Intelligence ETF2.21%
Global X Defense Tech ETF2.13%
Global X Data Center & Digital Infrastructure ETF2.05%

OakChart. NMRA. Cached 15 minutes.